skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ImlunestrantQuestion & answer

Imlunestrant · Medicine question

Why is ESR1 testing needed?

iatroX medicinesPublished 17 August 2026Reviewed 17 August 2026

The answer

Answer

The monotherapy licence is restricted to cancers with an activating ESR1 mutation, so a validated tumour or plasma test is required.

Sources for this answer

Inluriyo 200 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 1

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Imlunestrant

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Imlunestrant guide

More questions about Imlunestrant

What type of breast cancer is imlunestrant licensed to treat?Is imlunestrant chemotherapy?Can imlunestrant be taken with food?Can the tablets be crushed or split?Does imlunestrant affect liver blood tests?Can imlunestrant cause blood clots?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX